Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, whether an assessment has been made of the barriers preventing multiple myeloma patients accessing the most innovative treatments.

No specific assessment has been made of the barriers affecting access to the most innovative treatments for patients with multiple myeloma.

It is essential that a robust process is in place to ensure that patients get rapid access to the most innovative drugs that represent value for money to the National Health Service. The Cancer Drugs Fund has helped over 84,000 people to access the life-extending drugs they need, and NHS England and the National Institute for Health and Care Excellence are currently consulting on the future shape of the Fund to put it on a more sustainable footing.